Upgrade to SI Premium - Free Trial

Kythera Biophrarma (KYTH) Enters Hair Loss IP Agreement with Actelion Pharma, Univ. of Pennsylvania

February 10, 2015 4:31 PM
Kythera Biophrarma (NASDAQ: KYTH) has entered into separate license agreements with Actelion Pharmaceuticals Ltd. and the University of Pennsylvania for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Litigation Management Comments

Next Articles